Estudo do nitrito do condensado do exalado pulmonar em pacientes submetidos à cirurgia cardíaca com CEC by AUGUSTO, Viviane dos Santos et al.
15
1 - Mestre; Coordenadora do Programa de Aprimoramento em
Fisioterapia da Divisão de Cirurgia Cardiotorácica do Hospital das
Clínicas de Ribeirão Preto - FMRP/USP.
2 - Mestre; Fisioterapeuta do CTI da Unidade de Emergência do
Hospital das Clínicas de Ribeirão Preto - FMRP/USP.
3 - Mestre; Pós-graduanda do Departamento de Cirurgia e Anatomia
- FMRP/USP.
4 - Professora-doutora;(Coordenadora do Laboratório de Reatividade
Vascular de Função Endotelial do Departamento de Cirurgia e Anatomia
- FMRP/USP.
5 - Professor-doutor; Docente da Divisão de Cirurgia Torácica e
Cardiovascular do Departamento de Cirurgia e Anatomia - FMRP/USP.
6 - Professor Titular;  Chefe do Departamento de Cirurgia e Anatomia
da FMRP/USP.
This study was done at Department of Surgery and Anatomy, Ribeirão
Preto Faculty of Medicine, University of São Paulo, Avenida
Bandeirantes, 3900, Ribeirão Preto, São Paulo 14048-900, Brazil.
Viviane dos Santos AUGUSTO1, Graziela Saraiva REIS2, Verena Kise CAPELLINI3, Andrea Carla CELOTTO4,
Alfredo José RODRIGUES5, Paulo Roberto Barbosa EVORA6
Rev Bras Cir Cardiovasc 2011; 26.1: 15-20ARTIGO ORIGINAL
RBCCV 44205-1240
Estudo do nitrito do condensado do exalado pulmonar em pacientes submetidos à cirurgia cardíaca
com CEC
Nitrite exhaled breath condensate study in patients
undergoing cardiopulmonary bypass cardiac
surgery
Correspondence address:
Paulo Roberto Barbosa Evora. Rua Rui Barbosa, 367/15. CEP: 14015-
120 - Ribeirão Preto, SP, Brazil.
E-mail: prbevora@fmrp.usp.br
This study was supported by Fundação de Amparo à Pesquisa do
Estado de São Paulo (FAPESP) and Fundação de Apoio ao Ensino,
Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina
de Ribeirão Preto da Universidade de São Paulo (FAEPA/HCFMRP/
USP), SP, Brazil.
Artigo recebido em 14 de setembro de 2010
Artigo aprovado em 6 de janeiro de 2011
Resumo
Introdução: Estudos mostrando alterações das
concentrações de nitrito (NO
2
-) exalado, com biomarcador de
lesão, são raros em pacientes submetidos à cirurgia cardíaca.
Nesse contexto, o seu estudo no pré e pós-operatório de
cirurgias cardíacas poderá contribuir para novos dados clínicos.
Objetivo: O objetivo foi comparar os níveis de nitrito
(NO
2
-) do condensado do exalado pulmonar (CEP) no pré e
pós-operatório de cirurgia cardíaca com circulação
extracorpórea.
Métodos: Vinte e oito indivíduos foram alocados em três
grupos: 1) controle, 2) revascularização do miocárdio e 3)
correção valvar. Os níveis de NO
2
- foram dosados por
quimioluminiscência em amostras de CEP e sangue. Os
dados foram analisados pelos testes Mann-Whitney e
Wilcoxon.
Resultados: 1) Os níveis de NO
2
- no CEP dos grupos 2 e 3
no pré-operatório foram superiores aos do grupo controle;
2) Os níveis de NO
2
- no CEP do Grupo 3 foram maiores no
pré que no pós-operatório 24h; 3) Os níveis de NO
2
-
plasmático do Grupo 2 foram menores no pré que no pós-
operatório 24h e; 4) Não houve diferença na concentração
de NO
2
- plasmático entre os grupos 2 e 3 no pré-operatório.
Conclusão: Esses dados sugerem que a dosagem de NO
2
-
no CEP é viável em pacientes submetidos à cirurgia cardíaca.
Descritores: Nitritos. Óxido Nítrico. Testes de Função
Respiratória. Cirurgia Torácica. Procedimentos Cirúrgicos
Cardíacos.
Abstract
Background: There is a relative lack of studies on
postoperative changes in nitrite (NO
2
-) concentrations, a
marker of injury, following cardiac surgery. In this context,
investigations on how exhaled NO concentrations vary in
the postoperative period of cardiac surgery will certainly
contribute to new clinical findings.
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INTRODUCTION
Exhaled nitric oxide (NO) has been considered a potential
biomarker of lung injury after cardiac surgery with
cardiopulmonary bypass (CPB) [1]. The measurement of
pulmonary vasoreactivity is important not only in ischemia-
reperfusion, but also in patients with pulmonary
hypertension, sepsis, and acute respiratory distress
syndrome [2].
Bronchoscopy has long been employed for collection
of fluid from the lower respiratory tract. However, the
invasive nature of this technique has prompted growing
interest in the use of  exhaled breath condensate (EBC), a
simple, safe, and non-invasive approach to the sampling of
the lower airways [3,4]. Nonetheless, the dosing technique
is not well established yet, and the use of multiple devices
makes comparison of different studies difficult [5].
There is a relative lack of studies on postoperative
changes in nitrite (NO
2
-) concentrations, a marker of injury,
following cardiac surgery. In this context, investigations
on how exhaled NO concentrations vary in the postoperative
period of cardiac surgery will certainly contribute to new
clinical findings. It is worth mentioning that exhaled NO
expresses microcirculatory phenomena better than the
measurement of NO
2
- levels in plasma samples collected
from the pulmonary artery. Hence, assessment of exhaled
NO may be more representative of vasoreactivity in the
case of pulmonary hypertension.
The objective of this study was to compare the EBC NO
levels in both the pre and postoperative (24 hours) periods
of cardiac surgery.
METHODS
This prospective, nonrandomized study was approved
by the Ethics Committee of the Hospital of the Faculty of
Medicine of Ribeirão Preto, University of São Paulo (USP).
Twenty-eight adult patients of both sexes, aged between
26 and 71 years, were selected for this study and divided
into three groups: 1) Control, consisting of 14 healthy
volunteers who were not taking any medicine, including
smokers, former smokers, and nonsmokers; 2) seven
coronary artery bypass grafting (CABG) patients; and 3)
seven heart valve surgery patients.
The EBC collector device was mounted in polystyrene
box, and a mouth adaptor was added to the circuit, in order
to aid patients in breathing in the tidal volume (TV). After
correct placement of each circuit (mouth adaptor, plastic
tubes, and Eppendorf/1.5 mL), the plastic box was performed
with dry ice and positioned in the center of the polystyrene
box which was filled with crushed ice. Care was taken so as
not to allow direct contact between the two types of ice,
and the measured temperature was around -10º C.
Room air breathing volunteers were asked to rinse their
mouth prior to EBC collection, to minimize saliva
contamination. They were instructed to breathe in the TV
through the piece adapted to the mouth by closing the lips
around it. A calm respiratory pattern was requested during
sampling, which lasted 10 minutes. EBC collection in the
surgical group occurred at the following moments: a)
Preoperatively: preoperative spontaneously breathing
patients, and b) Postoperatively: spontaneously breathing
patients 24 hours after the end of the CPB surgery. The
EBC samples were stored at -70°C until NO dosage using
the NO/ozone chemiluminescence method (Sievers NOA
280i, Sievers, Boulder, CO, USA).
Disinfection of devices and materials was accomplished
with water and neutral liquid detergent Extran MaO
2
 (Merck),
followed by rinsing with tap water and Milli-Q water, and
drying with medical grade compressed air.
For measurement of plasma NO
2
- levels, 1.5 mL blood
samples were collected through a peripheral venous access
preoperatively, and through a central venous access
postoperatively. The blood sample was placed in a standard
collection tube (BD Vacutainer K2 EDTA) containing 0.08
mL heparin, transported on ice (-20ºC), and centrifuged at
Objective: The objective of this study was to compare the
EBC NO levels in both the pre and postoperative (24 hours)
periods of cardiac surgery.
Methods: Twenty-eight individuals were divided into
three groups: 1) control, 2) coronary artery bypass grafting,
and 3) valve surgery. The nitrite (NO
2
-) levels were
measured by chemiluminescence in blood samples and
exhaled breath condensate (EBC). Data were analyzed by
the Mann-Whitney and Wilcoxon tests.
Results: 1) Preoperatively, the EBC NO
2
- levels from groups
2 and 3 patients were higher than control individuals; 2) The
postoperative (24 hours) NO
2
- levels in the EBC from group 3
patients were lower compared with preoperative values; 3) The
NO
2
- levels in the plasma from group 2 patients were lower in
the preoperative compared with the postoperative (24h) values
and; 4) Preoperatively, there was no difference between groups
2 and 3 in terms of plasma NO
2
- concentrations.
Conclusion: These data suggest that NO measurement
in EBC is feasible in cardiac surgery patients.
Descriptors: Nitrites. Nitric Oxide. Respiratory Function
Tests. Thoracic Surgery. Cardiaca Surgical Procedures.
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5000 rpm for 10 minutes, at 4oC. The plasma was
deproteinated and stored at -70ºC for later NO
2
- level
measurement by NO/ozone chemiluminescence.
Statistical analysis
 The parameters were expressed as mean ± standard
deviation, with N corresponding to the number of patients.
Normality of data distribution was tested using the Shapiro-
Wilk test, which gave evidence of lack of normality. Thus,
data were analyzed by the Mann-Whitney and Wilcoxon
non-parametric tests, by means of the Prism 4.0 software.
Statistical significance was set at P <0.05.
 
RESULTS
 
The preoperative NO levels (4.28 ± 3.42) in the EBC
from surgical patients, were higher than those measured
in the EBC from the control group (1.34 ± 1.34) (P = 0.0065)
(Figure 1). In the case of valve disease, the preoperative
EBC NO values were significantly higher than the
postoperative levels (5.26 ± 4.52 and 0.70 ± 0.6, respectively;
P = 0.0173) (Figure 2).
In the surgical group who underwent CABG, there was
no statistical difference (P = 0.3095) between the preoperative
(3.74 ± 3.09) and postoperative (2.73 ± 4.66) EBC NO values
(Figure 3).
There were no significant differences in the preoperative
plasma NO
2
- concentrations of the three groups (P = 0.5031).
Indeed, similar values were detected in the control group
(0.17 ± 0.13) and preoperative CABG patients (0.18 ± 0.11),
whereas only slightly higher levels were found in the
preoperative valve patients (0.25 ± 0.16) compared with the
other groups (Figure 4).
Pre (0.25 ± 0.16) and postoperative (0.20 ± 0.19) plasma
NO
2
- concentrations in patients submitted to valve surgery
were similar (P = 0.6875). In the group that underwent CABG,
the plasma NO
2
- concentration significantly increased
postoperatively (preoperative level = 0.18 ± 0.11,
postoperative level = 0.47 ± 0.55; P = 0.0156) (Figure 5).
Fig. 1 - Comparison of EBC NO
2
- levels in the pre-operative period
and control group
Fig. 2 - Levels of NO
2
-  EBC in the pre-operative mitral valve
disease and postoperative 24 hours
Fig 3 - Levels of NO
2
-  EBC in the pre-operative and postoperative
24 hours of coronary artery bypass
Fig. 4 - Concentrations of NO
2
- plasma comparing the three groups
(control group, preoperative myocardial revascularization and
preoperative valve surgery
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DISCUSSION
     
After CPB cardiac surgery, patients may develop an
inflammatory response with increased release of pro-
inflammatory cytokines and NO [6]. Indeed, recent studies
have considered NO as an important biomarker of lung injury
after cardiac surgery [1,7].
NO concentrations in exhaled air are lower after lung
transplantation and in patients with acute respiratory
distress syndrome. However, results concerning exhaled
NO have only recently been recognized in the case of cardiac
surgery patients [1,7,8]. The inflammatory reactions
induced by CPB are related to the post-CPB period, and
these reactions lead to respiratory dysfunction associated
with reperfusion syndrome. They also cause interstitial
edema, impaired microcirculation of organs due to increased
protease activity, free radical production derived partly from
granulocytes, and reduced endogenous NO production.
In the present study, significantly higher EBC NO
concentrations were detected in cardiac surgery patients
preoperatively, compared with healthy individuals (control).
In the studied population, 43% of the surgical volunteers
were using drugs such as angiotensin-converting enzyme
(ACE) inhibitor (enalapril) and/or isosorbide dinitrate (NO
donor). The biochemical and pharmacological effects of
NO
3
- are identical to those of the NO-derived relaxing factor
from the endothelium; therefore, isosorbide dinitrate may
promote NO bioavailability. According to Sumino et al. [9],
because the measurement of exhaled NO is directly derived
from the lung, it is possible that ACE inhibitors cause larger
NO release in the latter organ compared with the serum
NO
x
 level in the peripheral venous blood. It is possible that
NO production in the systemic circulation is also promoted
by ACE inhibition, but this change is so small that NO
x
 is
rapidly excreted in urine without apparent alterations in the
NO
x
 serum level. It is thus more advantageous to use the
amount of NO measured in expired air as an indicator of the
NO level endogenously produced in the lung instead of
using the NO
x
 serum level.
This is because it is likely that enhanced NO
bioavailability induced by ACE inhibition results in larger
levels of NO radicals in exhaled air, which is not necessarily
accompanied by elevation in NO metabolites measured as
NO
x
 in the serum. In other words, it is possible that ACE
inhibition causes further increase in NO released by the
lungs compared with NO
x
 levels present in the plasma from
peripheral venous blood.  In addition, it can be speculated
that the reduced production of angiotensin II and / or the
accumulation of bradykinin in the lung tissue may be
responsible for the larger NO production in lung
components such as the pulmonary vascular endothelium,
bronchial epithelial cells, macrophages, and neurons in the
nasopharynx [9].
In the present investigation, it was observed that the
EBC NO levels decreased, fact that in the case of CABG, or
remained close to the preoperative values in the late
postoperative period (24 hours) of valve surgery. This
finding is similar to the results obtained by Kovesi et al. [7],
and a possible explanation may be related to the anatomical
origin of NO in exhaled air. Although vascular mechanisms
contribute to the production of exhaled NO, recent studies
suggest that bronchial epithelial cells are those that mostly
contribute to NO formation. This is sustained by the
distribution of nitric oxide synthase (NOS) isoenzymes in
the lungs.
The NOS isoforms iNOS and eNOS are found in the
epithelial cells of the airways and produce NO in large
quantities. Furthermore, small amounts of NO are produced
by NOS type III or eNOS. Thus, the pro-inflammatory
cytokines activated after surgery induce high NO production
by iNOS and affect the eNOS expression by destabilizing the
ribonucleic acid (mRNA) messenger of this isoenzyme,
thereby leading to its lower expression. Although iNOS is
quite active during cardiac surgery and the postoperative
period, there is no increase in exhaled NO levels because the
oxidative stress generated by the surgical procedure causes
NO consumption by the superoxide anion, which produces
peroxynitrite (OONO-) [7].
The vascular endothelium is part of an important
mechanism that contributes to vasodilation through the
endogenous release of prostacyclin and NO. However, the
endothelial function may decline with aging. In fact, the
vessels appear to be morphologically normal in elder
individuals, but a variety of metabolic abnormalities may
exist. Although the mechanisms that explain these
abnormalities remain unknown, the reduced NO production,
increased destruction of NO by superoxide, and changes
in membrane flags are compromised [10].
As already mentioned, the inflammatory reactions
induced by CPB are related to the post-CPB period and
culminate in respiratory dysfunction, associated with
Fig. 5 - Concentrations of NO
2
- plasma in the pre and postoperative
24 hours of valve surgery and myocardial revascularization
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CONCLUSIONS
 
There is a relative lack of studies in the literature on the
use of NO as a marker of lung injury in the postoperative
period of cardiac surgery. Thus, studies that demonstrate
the importance of NO in the exhaled breath condensate before
and after heart surgery will certainly contribute to new
clinical findings and may have diagnostic or therapeutic
relevance in different clinical situations. Therefore, the
following results of this work should be borne in mind:
1) A technique for collection of exhaled pulmonary
NO was employed here, which enabled measurement of
NO in exhaled air and was sensitive to changes in NO
x
values, thereby allowing comparison between NO levels
in the preoperative and postoperative periods of cardiac
surgery [14,16,17].
2) In the preoperative period, the surgical group
presented higher NO levels in the exhaled breath
condensate compared with the control group. The NO levels
in the exhaled breath condensate decreased in the
postoperative period in the case of patients undergoing
valve repair, whereas plasma NO
2
- levels increased in the
postoperative period (24 hours) in the case of coronary
artery bypass grafting surgical patients [18];
3) In the pre and postoperative (24 hours) periods of
cardiac surgery, there was no correlation between the exhaled
breath condensate NO levels and plasma NO
2
- levels [18].
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